Iain D. Dukes
Director, Iovance Biotherapeutics.
Companies
- Traws Pharma, Inc.Board member Oct 15, 2025 to now1
- Traws Pharma, Inc.Chief executive officer Oct 15, 2025 to now1
- Iovance BiotherapeuticsBoard member Aug 10, 2016 to now2
- Lomond Therapeutics Holdings, Inc.Chief executive officer Nov 5, 2024 to Nov 5, 20243
- Lomond Therapeutics Holdings, Inc.Chair Nov 5, 2024 to Nov 5, 20243
- Traws Pharma, Inc.Chair Apr 3, 2024 to Aug 7, 20244
- ImageneBio, Inc.Board member Mar 25, 2021 to Jun 10, 20245
- Theseus Pharmaceuticals, Inc.Board member Jun 13, 2023 to Feb 14, 20246
- Theseus Pharmaceuticals, Inc.Chair Jun 13, 2022 to Jun 13, 20227
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Iovance Biotherapeutics IOVA54,000 shares8$751.7K at $13.92Feb 20, 2024
- Traws Pharma, Inc. TRAW1,816,230 shares9$692.2K at $0.38Dec 12, 2025
- Theseus Pharmaceuticals, Inc.0 shares10Feb 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 12, 2025Granted 36,943 shares of Traws Pharma, Inc.9
- Apr 1, 2024Granted 1,645,100 shares of Traws Pharma, Inc.11
- Apr 1, 2024Granted 67,550 shares of Traws Pharma, Inc.11
- Apr 1, 2024Granted 66,687 shares of Traws Pharma, Inc.11
- Apr 1, 2024Granted 67,500 shares of Traws Pharma, Inc.12
- Feb 20, 2024Bought 32,000 shares at $9.15 of Iovance Biotherapeutics8
- Feb 14, 2024U 388,324 shares of Theseus Pharmaceuticals, Inc.10
- Nov 23, 2022Bought 10,000 shares at $6.10 of Iovance Biotherapeutics13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTraws Pharma, Inc., Board member
- 2
- 3
- 4SEC EDGARTraws Pharma, Inc., Chair
- 5SEC EDGARImageneBio, Inc., Board member
- 6
- 7SEC EDGARTheseus Pharmaceuticals, Inc., Chair
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Apr 3, 2024
- 12SEC EDGARForm 4 filed Aug 7, 2024
- 13SEC EDGARForm 4 filed Nov 28, 2022